BMC Neurology

official impact factor 2.80
Search for
Advanced search
BMC Neurology
Tools
Share this article
Open Access Highly Access Research article

Dose-dependent improvement of myoclonic hyperkinesia due to Valproic acid in eight Huntington's Disease patients: a case series

Carsten Saft*, Thorsten Lauter, Peter H Kraus, Horst Przuntek and Juergen E Andrich

Author Affiliations

Department of Neurology, Huntington-Center NRW, St. Josef Hospital, Bochum, Germany

For all author emails, please log on.

BMC Neurology 2006, 6:11 doi:10.1186/1471-2377-6-11

Published: 28 February 2006

Additional files

Additional File 1:

Case 1 without valproic acid treatment.

Format: MPG Size: 1.2MB Download file

Playing the movie within this page requires QuickTime 6.4 or later and JavaScript. Read more

Open Data

Additional File 2:

Case 1 with 900 mg valproic acid treatment

Format: MPG Size: 1.6MB Download file

Playing the movie within this page requires QuickTime 6.4 or later and JavaScript. Read more

Open Data

Additional File 3:

Case 7 without valproic acid treatment.

Format: MPG Size: 947KB Download file

Playing the movie within this page requires QuickTime 6.4 or later and JavaScript. Read more

Open Data

Additional File 4:

Case 7 with 1950 mg valproic acid treatment.

Format: MPG Size: 1.1MB Download file

Playing the movie within this page requires QuickTime 6.4 or later and JavaScript. Read more

Open Data